SEC Comment Letter for NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379) (NWBO) — Dec 13, 2007

NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379)
Date: Dec. 13, 2007 · CIK: 0001072379 · Accession: 0000000000-07-060453

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-33393

Date

December 13, 2007

Author

Jim B. Rosenberg

Form

UPLOAD

Company

NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379)

Letter

Mail Stop 6010 Via Facsimile and U.S. Mail December 13, 2007 Mr. Anthony P. Deasey Chief Financial Officer Northwest Biotherapeutics, Inc. 7600 Wisconsin Avenue, Suite 750 Bethesda, Maryland 20814

Re: Northwest Biotherapeutics, Inc. Form 10-K for fiscal year ended December 31, 2006 Filed April 17, 2007 File No. 000-33393

Dear Mr. Deasey:

We have completed our review of your Form 10-K and have no further comments at this time.

S i n c e r e l y ,

J i m B . R o s e n b e r g Senior Assistant Chief Accountant

Show Raw Text

Mail Stop 6010
Via Facsimile and U.S. Mail

                                                                              December 13, 2007

Mr. Anthony P. Deasey
Chief Financial Officer
Northwest Biotherapeutics, Inc.
7600 Wisconsin Avenue, Suite 750
Bethesda, Maryland 20814

Re: Northwest Biotherapeutics, Inc.
Form 10-K for fiscal year ended December 31, 2006
Filed April 17, 2007
File No. 000-33393

Dear Mr. Deasey:

            We have completed our review of your Form 10-K and have no further
comments at this time.

       S i n c e r e l y ,

       J i m  B .  R o s e n b e r g
      Senior Assistant Chief Accountant

SecProbe.io